GlassScriptPhysician profile
Lindsey E Nichols
NPI 1578717385
$2,830.07
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,988 · 2022: $792 · 2023: $50.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $623.94 | 2021-2022 | |
| Abbvie INC. | $383.00 | 2021-2023 | |
| Amarin Pharma, INC. | $337.63 | 2021-2022 | |
| Gilead Sciences, INC. | $158.26 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.97 | 2021-2022 | |
| Antares Pharma, INC. | $129.85 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $110.68 | 2021-2022 | |
| Novo Nordisk INC | $106.03 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.84 | 2021-2022 | |
| Almatica Pharma LLC | $97.89 | 2021 | |
| Merck Sharp & Dohme LLC | $93.80 | 2021 | |
| Amgen INC. | $73.22 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $69.77 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $65.86 | 2021-2022 | |
| Theratechnologies INC. | $51.58 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.06 | 2021-2022 | |
| Glaxosmithkline, LLC. | $47.32 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $38.47 | 2021 | |
| Clarus Therapeutics INC. | $32.73 | 2021 | |
| Upsher-Smith Laboratories LLC | $30.66 | 2021 | |
| Lilly USA, LLC | $30.03 | 2021-2022 | |
| Abbott Laboratories | $21.17 | 2021 | |
| Janssen Biotech, INC. | $19.37 | 2022 | |
| Avanir Pharmaceuticals, INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.